InsidersTradesSigma
Follow the TheraCryf plc share price and the full management transaction log of the company, a publicly traded company based in United Kingdom. Shares are quoted on the UK market, under the oversight of RNS (LSE). The latest transaction was reported on 16 October 2025 (Purchase). Among the most active insiders: Edward James Norman Wardle. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
TheraCryf plc es una empresa que cotiza en la Bolsa de Valores de Londres, centrada en el desarrollo de soluciones terapéuticas innovadoras. Se especializa en la investigación y comercialización de tratamientos para diversas enfermedades crónicas.